Chronic Stress: The Fingerprint Across Hormones and Inflammation
Chronic stress biomarkers are measurable signals in blood that show how persistently your body’s stress systems are switched on. They reflect the two main circuits that drive the stress response: the brain–adrenal hormone pathway (hypothalamic–pituitary–adrenal, or HPA axis) and the nerve–adrenal surge system (sympathetic–adrenal–medullary). Hormones like cortisol and its adrenal counterbalance DHEA (dehydroepiandrosterone) indicate how much the body is prioritizing survival mode over restoration. Adrenaline and noradrenaline (epinephrine, norepinephrine) and related metabolites point to ongoing “fight‑or‑flight” signaling. Immune and liver-derived proteins, such as inflammatory cytokines and C‑reactive protein (CRP), reveal whether stress is pushing the immune system toward a low‑grade, smoldering state. Metabolic markers, including glucose and insulin, show the cost of chronic fuel mobilization. Together, these biomarkers translate vague symptoms—fatigue, poor sleep, brain fog, irritability—into a readable map of stress biology. Testing helps identify which pathways are most engaged, provides a baseline for change, and allows you and your clinician to track whether lifestyle or therapeutic steps are moving your physiology back toward balance.
Why a Stress Panel Helps Decode Vague Symptoms
Chronic stress leaves fingerprints across your stress-response hormones and inflammation. Cortisol and DHEA‑S reflect how the brain–adrenal axis is coping with demand, while high-sensitivity CRP (hs‑CRP) signals the immune system’s inflammatory tone. Together they show how stress is influencing energy, sleep, mood, metabolism, cardiovascular health, and resilience.A healthy pattern shows cortisol highest in the morning and lowest at night, with values within the lab’s time‑of‑day range; mid‑range levels with a clear daily rhythm suggest good adaptability. DHEA‑S typically sits mid‑range for age and sex—higher in men and in teens/young adults, and declining with age. For hs‑CRP, below about 1 is considered lower risk, 1–3 average, and above 3 indicates higher inflammatory activity; the optimal is toward the low end. In pregnancy, cortisol and hs‑CRP tend to run higher while DHEA‑S falls later in gestation; children and teens naturally show rising DHEA‑S during adrenarche.When these markers run low, a flattened morning cortisol can reflect impaired hypothalamic–pituitary–adrenal drive or adrenal insufficiency, with fatigue, brain fog, dizziness, low blood pressure, and reduced stress tolerance. Low DHEA‑S hints at less anabolic balance—lower vigor, mood, or libido—and in youth may signal delayed adrenarche. Very low hs‑CRP usually just means minimal inflammation. Persistently high cortisol aligns with anxiety, poor sleep, central weight gain, higher glucose and blood pressure; very high DHEA‑S suggests adrenal overproduction; elevated hs‑CRP flags systemic inflammation and higher cardiovascular risk.Big picture, these biomarkers connect stress biology to immune function, metabolism, vascular health, and reproductive hormones. Tracking them helps map how chronic stress may drive insulin resistance, lipid changes, mood disorders, and long‑term risks such as hypertension, atherosclerosis, and osteoporosis.
What a Chronic-Stress Panel Reveals and Where It Stops
Chronic stress blood testing provides a window into how your body manages and adapts to ongoing demands. At a systems level, chronic stress can disrupt energy balance, metabolism, cardiovascular function, cognitive performance, reproductive health, and immune resilience. At Superpower, we assess three key biomarkers—Cortisol, DHEAS, and high-sensitivity C-reactive protein (hs-CRP)—to map your body’s stress response and its broader physiological impact.Cortisol is the primary hormone released during stress, orchestrating energy mobilization and alertness. DHEAS (dehydroepiandrosterone sulfate) is a hormone that counterbalances some effects of cortisol and supports tissue repair, immune function, and mood. hs-CRP is a sensitive marker of inflammation, reflecting how stress may be influencing immune activity and tissue health. Together, these markers reveal the interplay between your stress response system (the hypothalamic-pituitary-adrenal axis), hormone balance, and inflammation.Balanced cortisol and DHEAS levels suggest your body is maintaining stability (homeostasis) under stress, supporting healthy function across multiple systems. Persistent elevation or suppression of cortisol, low DHEAS, or increased hs-CRP may indicate that chronic stress is straining your body’s adaptive capacity, potentially affecting energy, immunity, and long-term health.Interpretation of these biomarkers depends on context. Age, sex, pregnancy, acute illness, medications (such as steroids or hormone therapy), and even the time of day can influence results. Laboratory methods and reference ranges also vary, so results are best understood within your personal and clinical context.
FAQs
It measures how your stress and inflammation systems are behaving, not just how you feel. Superpower tests your blood for Cortisol, DHEAS, and hs-CRP. Cortisol reflects real-time stress signaling from the brain–adrenal axis (HPA axis). DHEAS shows adrenal reserve and counterbalance to cortisol. hs-CRP captures low-grade systemic inflammation. Together they map physiologic stress load (allostatic load).
To quantify stress biology and reveal hidden strain on key systems. Abnormal cortisol patterns and DHEAS shifts signal HPA axis dysregulation; elevated hs-CRP indicates inflammatory burden. This profile can explain fatigue, poor sleep, weight and mood changes, and helps track cardiometabolic and immune risk over time. It provides an objective baseline and a way to monitor change.
Yes. With Superpower, our team member can organise a blood draw in your home. We schedule morning timing for cortisol/DHEAS, handle samples to spec, and deliver results securely.
Start with a baseline, then retest in 3–6 months to assess trend. Keep timing consistent—draw morning cortisol at the same hour. If hs-CRP is high during an acute illness, repeat 2–4 weeks after recovery to confirm persistent inflammation. Test sooner if symptoms shift meaningfully.
Time of day strongly affects cortisol; aging lowers DHEAS. Acute infection, injury, surgery, pain, and chronic conditions raise hs-CRP. Pregnancy, menstrual phase, oral contraceptives, glucocorticoids, antidepressants, androgen therapy, intense exercise, poor sleep, alcohol, smoking, and obesity can shift these values. Collection timing and recent stressors matter.
Prefer a morning draw (around 7–10 am) and use the same time for follow-ups. Avoid vigorous exercise and alcohol for 24 hours. If you’re acutely ill and want a chronic baseline, wait until recovered. Fasting isn’t required for these markers, but follow any fasting instructions if other tests are bundled. Take regular meds unless told otherwise and note steroid use.
References
- Lightman, S. L., Birnie, M. T., & Conway-Campbell, B. L. (2020). Dynamics of ACTH and cortisol secretion and implications for disease. Endocrine Reviews, 41(3), bnaa002. https://doi.org/10.1210/endrev/bnaa002
- Laughlin, G. A., & Barrett-Connor, E. (2000). Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. The Journal of Clinical Endocrinology and Metabolism, 85(10), 3561-3568. https://doi.org/10.1210/jcem.85.10.6861
- Suh, E., Cho, A. R., Haam, J. H., Gil, M., Lee, Y. K., & Kim, Y. S. (2023). Relationship between serum cortisol, dehydroepiandrosterone sulfate (DHEAS) levels, and natural killer cell activity: a cross-sectional study. Journal of Clinical Medicine, 12(12), 4027. https://doi.org/10.3390/jcm12124027
- Wang, A., Liu, J., Li, C., Gao, J., Li, X., Chen, S., Wu, S., Ding, H., Fan, H., & Hou, S. (2017). Cumulative exposure to high-sensitivity C-reactive protein predicts the risk of cardiovascular disease. Journal of the American Heart Association, 6(10), e005610. https://doi.org/10.1161/jaha.117.005610
- Pepys, M. B., & Hirschfield, G. M. (2003). C-reactive protein: a critical update. The Journal of Clinical Investigation, 111(12), 1805-1812. https://doi.org/10.1172/jci18921






































.avif)
